BeiGene Company Insiders

ONC Stock   320.37  13.50  4.04%   
BeiGene's insiders are aggressively selling. The analysis of the overall insider sentiment regarding BeiGene suggests that all insiders are panicking. BeiGene employs about 11 K people. The company is managed by 14 executives with a total tenure of roughly 25667 years, averaging almost 1833.0 years of service per executive, having 785.71 employees per reported executive.

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-10-08Chan Henry LeeDisposed 10671 @ 350.4View
2025-09-16John OylerDisposed 27803 @ 325.71View
2025-09-10Chan Henry LeeDisposed 10006 @ 325.53View
2025-09-09Lai WangDisposed 5000 @ 350.06View
2025-09-05Corazon (Corsee) D SandersDisposed 2665 @ 337View
2025-09-02Titus B BallDisposed 122 @ 326.76View
2025-08-14Xiaobin WuDisposed 39936 @ 305.06View
2025-08-13Xiaobin WuDisposed 49858 @ 304.16View
2025-08-01Aaron RosenbergDisposed 1190 @ 290.47View
2025-07-30Chan Henry LeeDisposed 920 @ 304.6View
2025-07-29Lai WangDisposed 4041 @ 302.49View
2025-07-18Lai WangDisposed 700 @ 300View
2025-07-09John OylerDisposed 27802 @ 253.38View
2025-06-24Xiaodong WangDisposed 2007 @ 265.5View
2025-06-23Lai WangDisposed 1028 @ 260View
2025-06-17Xiaobin WuDisposed 630 @ 250.87View
Monitoring BeiGene's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

BeiGene's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with BeiGene's future performance. Based on our forecasts, it is anticipated that BeiGene will maintain a workforce of about 11000 employees by February 2026.
 
Yuan Drop
 
Covid

BeiGene Management Team Effectiveness

The company has Return on Asset of 0.0169 % which means that on every $100 spent on assets, it made $0.0169 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0181 %, implying that it generated $0.0181 on every 100 dollars invested. BeiGene's management efficiency ratios could be used to measure how well BeiGene manages its routine affairs as well as how well it operates its assets and liabilities. As of January 9, 2026, Return On Tangible Assets is expected to decline to -0.11. In addition to that, Return On Capital Employed is expected to decline to -0.19. At present, BeiGene's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.35, whereas Total Assets are forecasted to decline to about 3.5 B.
As of January 9, 2026, Common Stock Shares Outstanding is expected to decline to about 70.3 M
BeiGene holds a total of 101.81 Million outstanding shares. 30% of BeiGene outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2014-03-31
Previous Quarter
112.8 M
Current Value
114.5 M
Avarage Shares Outstanding
71.8 M
Quarterly Volatility
31.1 M
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as BeiGene in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of BeiGene, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

BeiGene Workforce Comparison

BeiGene is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 363,110. BeiGene holds roughly 11,000 in number of employees claiming about 3% of equities under Health Care industry.
The company has Net Profit Margin of 0.01 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.12 %, which entails that for every 100 dollars of revenue, it generated $0.12 of operating income.

BeiGene Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BeiGene insiders, such as employees or executives, is commonly permitted as long as it does not rely on BeiGene's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, BeiGene insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

BeiGene Notable Stakeholders

A BeiGene stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BeiGene often face trade-offs trying to please all of them. BeiGene's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BeiGene's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
John OylerExecutive CoFounderProfile
Xiaodong WangCoChairman CoFounderProfile
Wang LaiPresident DevelopmentProfile
Xiaobin WuPresident COOProfile
Chan LeeGeneral VPProfile
Titus BallVP OfficerProfile
Liza HeapesHead RelationsProfile
Marcello DamianiChief OfficerProfile
Eleanor DuffSenior CommunicationsProfile
Aaron RosenbergChief OfficerProfile
Graham HardimanGlobal ResourcesProfile
Yang JiChief OfficerProfile
Yan QiSenior ChinaProfile
Mark LanasaSenior TumorsProfile
String symbol = request.getParameter("s");

About BeiGene Management Performance

The success or failure of an entity such as BeiGene often depends on how effective the management is. BeiGene management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BeiGene management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BeiGene management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.10)(0.11)
Return On Capital Employed(0.18)(0.19)
Return On Assets(0.10)(0.10)
Return On Equity(0.22)(0.23)
Please note, the presentation of BeiGene's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BeiGene's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BeiGene's management manipulating its earnings.

BeiGene Workforce Analysis

Traditionally, organizations such as BeiGene use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BeiGene within its industry.

BeiGene Manpower Efficiency

Return on BeiGene Manpower

Revenue Per Employee346.4K
Revenue Per Executive272.2M
Net Loss Per Employee58.6K
Net Loss Per Executive46.1M
Working Capital Per Employee161.5K
Working Capital Per Executive126.9M

Complementary Tools for BeiGene Stock analysis

When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stocks Directory
Find actively traded stocks across global markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format